Hem Pharma, Inc.(KR:376270)
₩25,900.00+1500.00 (+6.15%)
KR:376270
Hem Pharma, Inc. earnings date
₩25,900.00
At close:+1500.00 (+6.15%)
Hem Pharma, Inc. (376270) Q2 2026 Earnings Report
KR:376270 Q2 2026 EPS Results
- Actual EPS
- KRW 209.24
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -KRW 469.69
KR:376270 Q2 2026 Revenue Results
- Actual Revenue
- KRW 4.57B
- Expected Revenue
- KRW 10.17B
- Beat/Miss
- Missed by -KRW 5.60B
- YoY Revenue Growth
- +60.82%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/21/2026
- Time
- TBA
- Conference Call
- Friday, August 21, 2026
KR:376270 Upcoming Earnings
Hem Pharma, Inc.'s next earnings date is estimated for March 25, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
KR:376270 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 25, 2027 | 2026 (Q4) | ―- | -2055.87 | ― | ― |
| Nov 20, 2026 | 2026 (Q3) | ―535.27 | -502.05 | 206.62% (+1037.32) | |
| Aug 21, 2026 | 2026 (Q2) | ―209.24 | -469.69 | 144.55% (+678.93) | |
| May 11, 2026 | 2026 (Q1) | ―-580.38 | -335.28 | -73.11% (-245.10) | |
| Mar 18, 2026 | 2025 (Q4) | ―-2055.87 | -294.58 | -597.89% (-1761.28) | |
| Nov 28, 2025 | 2025 (Q3) | ―-502.05 | -312.36 | -60.73% (-189.69) | |
| Aug 26, 2025 | 2025 (Q2) | ―-469.69 | -243.54 | -92.86% (-226.15) | |
| May 21, 2025 | 2025 (Q1) | ―-335.28 | -248.19 | -35.09% (-87.08) | |
| Mar 21, 2025 | 2024 (Q4) | ―-294.58 | -327.63 | 10.09% (+33.05) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

